Patient Support Program KPIs: Measuring Enrollment, Adherence and Operational Performance
The enrollment, adherence, and operational KPIs that actually measure PSP performance, plus how digital platforms track them in real time.
Key takeaways
- PSP performance should be evaluated across four distinct categories: enrollment and reach, clinical adherence, operational efficiency, and overall program value.
- Reporting cumulative enrollment numbers masks critical trends; teams should track rate-based, time-bound metrics with clearly documented numerator and denominator logic.
- Operational KPIs lose actionable value if reviewed monthly, requiring real-time tracking from operational records rather than manually maintained spreadsheets.
Reviewed by the CareSync Medical Team · Last reviewed
On this page
Patient support program (PSP) performance is best measured across four KPI categories: enrollment and reach, clinical adherence, operational efficiency, and program value. Tracking a single headline number — total patients ever enrolled — tells leadership almost nothing about whether the program is working; the four-category framework below is what turns PSP data into a decision-ready report for Medical Affairs and Market Access.
Define the denominator before comparing performance
Define referral-to-enrollment conversion as enrolled patients divided by eligible referrals within the same cohort and observation window. Record consent, activation and persistence as separate stages; do not combine patients from different periods. Report contact timeliness from a documented starting event to a completed contact, with unreachable cases visible separately. Refill availability is not proof that medication was taken, and a support contact is not a clinical outcome. Show missing records and exclusions alongside each result. Agree ownership of each measure, its update frequency and the action triggered by a deterioration. Comparisons need consistent populations and definitions.
Why most PSP KPI frameworks fail
The most common mistake is reporting cumulative, vanity-style metrics — "total patients enrolled since launch" — instead of rate-based, time-bound metrics that show current program health. A cumulative enrollment number can rise every month even while active enrollment rate, time-to-first-contact, and 90-day adherence are all quietly deteriorating. KPIs should answer: is the program reaching the right patients, keeping them engaged, running efficiently, and generating a value story leadership can act on.
The four KPI categories
| Category | Example KPIs | What it tells you |
|---|---|---|
| Enrollment & reach | Enrollment rate, time to enrollment, eligible-patient capture rate | Whether the program is reaching its addressable patient population |
| Clinical / adherence | Adherence or refill-compliance rate, discontinuation rate at 30/60/90 days | Real-world therapy persistence, not just sign-up |
| Operational efficiency | Average time to first nurse contact, case resolution time, AE report turnaround time | Execution quality of the field and support team |
| Program value | Issues resolved without an unplanned physician visit, patient satisfaction score, cost per actively-engaged patient | The narrative Market Access needs to defend program budget |
Why Excel-based tracking breaks down at scale
Spreadsheet-based KPI tracking works for a single brand with a handful of field staff. It can become harder to maintain when record volumes increase or a second brand joins the same team's workload: data entry lags behind real events, definitions drift between team members (what counts as "enrolled"?), and Medical Affairs ends up reviewing a report that's already weeks stale by the time it reaches a steering committee.
Building a KPI dashboard your teams can trust
- Single source of truth: KPIs calculated from the same enrollment and visit records the field team logs in — not a parallel manually-maintained tracker.
- Real-time, not monthly: operational KPIs like time-to-first-contact lose their value if they're reviewed a month after the fact.
- Role-based views: Medical Affairs needs therapy-support/adherence KPIs; Market Access needs program value and cost; Operations needs case-resolution and AE turnaround — one dashboard, different lenses.
- Defined, documented metric logic: every KPI should have a written definition (numerator, denominator, time window) so numbers survive a team handover.
A note on benchmarking
Treat any external PSP benchmark you encounter with caution unless it names its source, patient population, and methodology — adherence and enrollment rates vary widely by therapy area, condition severity, and program design, and no single public benchmark fits every program. The more useful comparison is your own program's trend over time: is this quarter's 90-day adherence rate better or worse than last quarter's, under the same KPI definitions.
FAQ
What's the single most important PSP KPI?
There isn't one — a program that enrolls well but has poor 90-day adherence, or vice versa, is failing somewhere the headline number won't show. Review all four categories together.
How often should PSP KPIs be reported to leadership?
Operational KPIs in real time or weekly; a consolidated enrollment/adherence/value report monthly or quarterly, depending on program maturity and the governance cadence your Market Access team has set.
Can KPI tracking be automated from day one of program launch?
This can be planned if the underlying platform logs enrollment, visits, and case data structurally from the start — retrofitting KPI tracking onto a spreadsheet-based program later means reconstructing historical data that was never captured in a consistent format.
Applying this framework to CareSync PSP Connect
CareSync PSP Connect supports modular discussions around enrollment, consent, educator follow-up, adherence support and tracked safety handoffs. Confirm the proposed configuration, hosting, access controls, integrations and reporting cadence with the implementation team. This article is a buyer framework, not a promise that every requested function is included or already deployed. Screens and cover dashboards are illustrative, not patient data or measured customer results. Clinical and pharmacovigilance decisions remain with the responsible professionals.
Related PSP buyer guides
Sources and scope
This is an editorial procurement framework, not a clinical study, market-price survey or validated outcomes model. Use current official guidance for applicable obligations.
Prepared by the CareSync Medical Team. This article is educational, not medical advice or a substitute for clinical, legal or regulatory review. Research findings are source-specific, not measured CareSync outcomes.